Exogenous Cushing's syndrome and glucocorticoid withdrawal.
about
Management issues with exogenous steroid therapyCushing's diseaseGlucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoidsSeparating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatmentAdrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report.A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome.Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threatFactitious Cushing's syndrome masquerading as Cushing's disease.Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasiaInhalational Steroids and Iatrogenic Cushing's SyndromeCushing's syndrome: epidemiology and developments in disease management.Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathwayGlucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects.Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.Epimedium flavonoids counteract the side effects of glucocorticoids on hypothalamic-pituitary-adrenal axisIatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.Cushing's syndrome: from physiological principles to diagnosis and clinical care.A new illicit opioid dependence outbreak, evidence for a combination of opioids and steroids.Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.Delayed recovery of hypothalamo-pituitary-adrenal axisIatrogenic Cushing's Syndrome After Topical Steroid Therapy for PsoriasisAcute psychosis caused by hypothyroidism following radioactive iodine treatment of Graves' disease.Iatrogenic Cushing's syndrome and osteoporosis due to an interaction between fluticasone and ritonavir.Consequences of low birth weight, maternal illiteracy and poor access to medical care in rural India: infantile iatrogenic Cushing syndrome.Perioperative Endocrine Therapy for Patients with Cushing's Syndrome Undergoing Retroperitoneal Laparoscopic AdrenalectomyPreventing Cushing: Iatrogenic Cushing Syndrome due to Ritonavir-Fluticasone InteractionGenomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation.Adrenal insufficiency secondary to inappropriate oral administration of topical exogenous steroids presenting with hypercalcaemia.A case series of abuse of a new opioid combination, Norjizak.Cushing syndrome induced by parents: a report of two cases.Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.Steroid management in newly diagnosed glioblastoma.Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis.Cushing's syndrome and chronic venous ulceration--a clinical challenge.Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.
P2860
Q24564449-658D2D35-DD2A-4FD3-861D-EC0FD9943D32Q26827386-BD5528F4-32E1-41B2-8BA5-720BA825C701Q28509978-8E0F2968-C427-48B9-A650-5CA10701C2EFQ30318833-B512B5D1-666A-4604-967E-FF20323814D5Q30439373-DCF3DBCD-FACE-4A5D-B434-9BBC202861D7Q33650871-EABA6E07-CFBD-41C9-BBF7-D1BAAF75ABE8Q34228984-5F1E082C-2C40-4C42-AE5B-5C31C107B56CQ34376630-C0076932-391D-4387-9A04-26257D233F70Q34431162-5B759582-729B-4AE8-AA5C-5C98411FE4D7Q35056151-47DC4445-EA86-4C6C-997E-0C8E9473656CQ35531889-5E2302E3-17CD-48F8-8296-78F98A3F1B6CQ35995856-EA7DB088-38D7-4A62-9975-C02C61C9F3D3Q36017886-F83CC8FE-AD8F-4AAE-A5E3-BECD9119B3B2Q36242209-75616B34-C7D0-4D0F-814F-1F4A4A605400Q37135137-6C0BD002-B46C-4BCD-81AD-0D3740B916F5Q37224876-92F31EDC-4C99-49AC-A852-3C599AD38DC5Q38115415-8BB308DD-703C-4243-9BBF-E0650B94BB1DQ38284048-A06BF680-774C-4C47-A151-1EA6852FB2DAQ38494329-008BAA0A-4C1A-433B-824A-219485A28375Q38497174-96F05364-B953-4C34-BF54-C5FAC5A4129AQ38595691-4527C755-DD0E-404D-AD2F-ACA0ED2822D7Q38596773-DB48A44B-F3A5-41BB-8CEA-D3212CCC5801Q39582960-D2AF87B6-E048-4B55-BB17-3FFF9A16DEC4Q40931267-6C0AC89C-68C6-4B44-A0EF-4D1F3CECBE13Q41461247-E88293EF-DFCD-4394-8C18-BEF4C3171F90Q41543457-D2A8B59C-C480-4943-B1DE-D8985CBEEB45Q41698961-28E26B36-14E4-485D-8A26-B314AD3F05C8Q41954335-05EF53E3-04BB-456B-B4A3-030D410218E1Q42221445-29D001AC-0ED3-41D1-9E8B-F1C47867B0B2Q42616659-7E8EC648-2CA9-4D8C-8095-B2DBD7E435A2Q43045142-A02D117E-3E8E-44A4-ADBD-6B4BF4B537B7Q44013360-F8A22312-B7EE-4C91-B2CD-A63AC8969899Q44233551-EBFA3925-0A6F-4149-8F80-943651BB7A98Q47138484-C2530EFB-C632-4F24-A404-55EADBC96E6CQ48331594-BB798C8F-A459-4AEF-AD4E-A85822650723Q51744585-07CB9EE7-DB81-4658-9FE7-CF8E4FECC27A
P2860
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@ast
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@en
type
label
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@ast
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@en
prefLabel
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@ast
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@en
P1476
Exogenous Cushing's syndrome and glucocorticoid withdrawal.
@en
P2093
Matthew C Leinung
Rachel L Hopkins
P304
371-84, ix
P356
10.1016/J.ECL.2005.01.013
P577
2005-06-01T00:00:00Z